39 results on '"Denis, M.G."'
Search Results
2. Résistance aux anti-EGFR via l’acquisition successive et cumulée de deux nouvelles addictions oncogénique BRAF et ALK
3. Actualisation des recommandations de prise en charge du mélanome stades I à III
4. Génotypage des cancers anaplasiques de la thyroïde : retour sur 3 ans d’expérience au CHU de Nantes
5. 1050P Association of ctDNA quantification with prognosis and early prediction of response to first-line osimertinib in NSCLC patients
6. 1130P Anchored multiplex PCR-based targeted sequencing for the detection of fusion transcripts in FFPE samples of non-small cell lung cancer patients
7. 1359P Relationship between tumor TP53 gene mutation, circulating anti-p53 antibodies and response to first-line osimertinib in EGFR-mutated NSCLC patients
8. 2343P Evolution of circulating tumour DNA analysis in France over 5 years
9. 1354P Detection of EGFR T790M in EGFR activating mutation-positive advanced non-small cell lung cancer (NSCLC): Comparison between two assays on circulating tumour (ct)DNA
10. Molecular mechanisms involved in the antiproliferative effect of two COX-2 inhibitors, nimesulide and NS-398, on colorectal cancer cell lines
11. Results of a global external quality assessment scheme for EGFR testing on liquid biopsy
12. First national external quality assessment for the interpretation of somatic variants: Assessment of 25 variants in colorectal, lung, ovarian cancers and melanoma in France
13. 544 Prognostic biomarkers based on melanoma cell-lines in stage III melanoma patients
14. Étude des mutations activatrices des gènes BRAF et KRAS au cours de la carcinogenèse associée aux maladies inflammatoires chroniques de l’intestin
15. 1413P - Results of a global external quality assessment scheme for EGFR testing on liquid biopsy
16. 104P - First national external quality assessment for the interpretation of somatic variants: Assessment of 25 variants in colorectal, lung, ovarian cancers and melanoma in France
17. French updated recommendations in Stage I to III melanoma treatment and management
18. Circulating free tumour-derived DNA (ctDNA) to detect EGFR mutation in patients (pts) with advanced NSCLC (aNSCLC): French subset analysis of the ASSESS study
19. External quality assessment of EGFR testing in circulating DNA: a french pilot study
20. Leptin and its potential interest in assisted reproduction cycles
21. Détection de mutations de BRAF dans le plasma de patients atteints de mélanome métastatique
22. EGFR Mutation Detection in Plasma of Lung Tumor Patients in the Absence of Contributive Tissue is a Relevant Alternative for Prescription of Tyrosine Kinase Inhibitors in a Routine Clinical Setting
23. In search for environmental education sustainability
24. Egfr Testing from Circulating Cell-Free Dna: Ready for Routine Practice
25. The Cell-Free Fraction of Pleural Effusions is an Important Source of Dna Suitable for Molecular Testing
26. Détection de mutations de BRAF, dans le plasma de patients atteints de mélanome métastatique
27. 69P - External quality assessment of EGFR testing in circulating DNA: a french pilot study
28. 60P - Circulating free tumour-derived DNA (ctDNA) to detect EGFR mutation in patients (pts) with advanced NSCLC (aNSCLC): French subset analysis of the ASSESS study
29. 106PD - EGFR Mutation Detection in Plasma of Lung Tumor Patients in the Absence of Contributive Tissue is a Relevant Alternative for Prescription of Tyrosine Kinase Inhibitors in a Routine Clinical Setting
30. Prognostic value of peripheral blood double detection of CK19 and MUC1 mRNA positive cells detected by RT-quantitative PCR in 94 breast cancer patients with a follow up of 9 years
31. Le maintien de l’expression de la calréticuline est associé avec la différenciation mucineuse des adénocarcinomes coliques humains
32. C21 - Rôle pivot de l’ADAM17/TACE exprimée par les myocytes humains dans l’inflammation intestinale
33. 249P - The Cell-Free Fraction of Pleural Effusions is an Important Source of Dna Suitable for Molecular Testing
34. 250P - Egfr Testing from Circulating Cell-Free Dna: Ready for Routine Practice
35. Assignment1 of the serologically defined colon cancer antigen 1 gene (SDCCAG1) to human chromosome band 14q22 by in situ hybridization
36. 138 O - Detection of colorectal carcinoma metastases in blood
37. A novel member of the immunoglobulin gene superfamily expressed in rat carcinoma cell lines.
38. Em busca da sustentabilidade educadora ambientalista
39. Détection de mutations de BRAFdans le plasma de patients atteints de mélanome métastatique
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.